Well it seems the market doesn't agree with me and didn't mind the result. I am less worried about coronavirus etc and more worried about high valuations on markets in general.
My problem with the result was that organic growth felt weak. Aurora boosted headline earnings nicely, but organic NPAT growth was only around 3%. The market seems to want to look through regulatory issues in the US imaging component of the earnings. Still can't complain about a 50% return in 14 months or so. Interestingly that gain is on very little EPS growth.
Ann: CEO Presentation Half Year Results to 31 December 2019, page-7
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.37 |
Change
0.120(0.46%) |
Mkt cap ! $12.66B | |||
| Open | High | Low | Value | Volume |
| $26.00 | $26.38 | $25.96 | $31.28M | 1.193M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2895 | $26.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.38 | 3597 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| SHL (ASX) Chart |